135 related articles for article (PubMed ID: 38739247)
1. Study on the regulatory mechanism of latent membrane protein 2A on GCNT3 expression in nasopharyngeal carcinoma.
Chen Y; Zhang Y; Duo S; Liu W; Luo B
Virus Genes; 2024 May; ():. PubMed ID: 38739247
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus-Encoded Latent Membrane Protein 2A Downregulates GCNT3 via the TGF-β1/Smad-mTORC1 Signaling Axis.
Liu J; Zhang Y; Yu C; Li J; Liu W; Luo B
J Virol; 2021 Apr; 95(10):. PubMed ID: 33658337
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction.
Lin Z; Wan X; Jiang R; Deng L; Gao Y; Tang J; Yang Y; Zhao W; Yan X; Yao K; Sun B; Chen Y
J Virol; 2014 Oct; 88(20):11872-85. PubMed ID: 25100829
[TBL] [Abstract][Full Text] [Related]
4. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
5. Role of Peroxiredoxin 1 Induced by Epstein-Barr Virus Infection in Nasopharyngeal Carcinoma.
Noh MH; Kim HY; Kim DH; Moon SH; Hur DY
Anticancer Res; 2024 Apr; 44(4):1425-1440. PubMed ID: 38537989
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded LMP2A stimulates migration of nasopharyngeal carcinoma cells via the EGFR/Ca
Liang J; Zheng S; Xiao X; Wei J; Zhang Z; Ernberg I; Matskova L; Huang G; Zhou X
Biol Open; 2017 Jun; 6(6):914-922. PubMed ID: 28512118
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma.
Heussinger N; Büttner M; Ott G; Brachtel E; Pilch BZ; Kremmer E; Niedobitek G
J Pathol; 2004 Jun; 203(2):696-9. PubMed ID: 15141385
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.
Kong QL; Hu LJ; Cao JY; Huang YJ; Xu LH; Liang Y; Xiong D; Guan S; Guo BH; Mai HQ; Chen QY; Zhang X; Li MZ; Shao JY; Qian CN; Xia YF; Song LB; Zeng YX; Zeng MS
PLoS Pathog; 2010 Jun; 6(6):e1000940. PubMed ID: 20532215
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
[TBL] [Abstract][Full Text] [Related]
11. Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.
Zhu J; Kamara S; Cen D; Tang W; Gu M; Ci X; Chen J; Wang L; Zhu S; Jiang P; Chen S; Xue X; Zhang L
Cell Death Dis; 2020 Apr; 11(4):213. PubMed ID: 32238802
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus LMP1-Activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties.
Zhu N; Wang Q; Wu Z; Wang Y; Zeng MS; Yuan Y
J Virol; 2022 Mar; 96(5):e0194121. PubMed ID: 35019715
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.
Fotheringham JA; Coalson NE; Raab-Traub N
J Virol; 2012 Oct; 86(19):10308-20. PubMed ID: 22837212
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of adipose triglyceride lipase by EB viral-encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma.
Zheng S; Matskova L; Zhou X; Xiao X; Huang G; Zhang Z; Ernberg I
Mol Oncol; 2020 Dec; 14(12):3234-3252. PubMed ID: 33064888
[TBL] [Abstract][Full Text] [Related]
15. Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies.
Chen Y; Yao K; Sun H; Qing J; Peng GY
Chin Med J (Engl); 2005 May; 118(9):725-30. PubMed ID: 15899133
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus-Encoded Products Promote Circulating Tumor Cell Generation: A Novel Mechanism of Nasopharyngeal Carcinoma Metastasis.
Yang Z; Wang J; Zhang Z; Tang F
Onco Targets Ther; 2019; 12():11793-11804. PubMed ID: 32099385
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of EBV LMP2A in nasopharyngeal cancer specimens].
Xu J; Yao K; Yu C; Chen X; Li B; Sun H; Zhou F
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jun; 19(11):484-7. PubMed ID: 16124641
[TBL] [Abstract][Full Text] [Related]
18. [Expression of LMP2A, E-Cadherin and fibronectin in nasopharyngeal carcinoma and its clinical significance].
Zhao L; Rao J; Luo B; Chen X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(2):132-6. PubMed ID: 25989660
[TBL] [Abstract][Full Text] [Related]
19. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22.
Lung RW; Tong JH; Sung YM; Leung PS; Ng DC; Chau SL; Chan AW; Ng EK; Lo KW; To KF
Neoplasia; 2009 Nov; 11(11):1174-84. PubMed ID: 19881953
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth.
Huo H; Hu G
Infect Agent Cancer; 2019; 14():30. PubMed ID: 31673282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
